Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric cancer

Journal of Surgical Oncology

Volumn 64, Issue 4, 1997, Pages 318-323

  Içli, Fikri ^a   Karaoguz, Handan ^a   Akbulut, Hakan ^a   Dinçol, Dilek ^a   Demirkazik, Ahmet ^a   Çay, Filiz ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

advanced gastric cancer; chemotherapy; cisplatin; doxorubicin; etoposide

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; STOMACH CANCER; VOMITING;

ADENOCARCINOMA; ADULT; AGED; ALOPECIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DOXORUBICIN; ETOPOSIDE; FEMALE; HUMANS; LEUKOPENIA; MALE; MIDDLE AGED; NAUSEA; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; VOMITING;

EID: 0030937497     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199704)64:4<318::AID-JSO13>3.0.CO;2-Z     Document Type: Article

References (22)

1. Karaoguz H, Içli F: Cancer problem in Türkiye. J Ankara Med School 1993;15:547-558.
2. Preusser P, Achterrath W, Wilke H, et al.: Chemotherapy of gastric cancer. Cancer Treat Rev 1988;15:257-277.
3. Macdonald JS, Gohmann JJ: Chemotherapy of advanced gastric cancer: Present status, future prospects. Semin Oncol 1988; 15(suppl 4):42-49.
4. Preusser P, Wilke H, Achterrath W, et al.: Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer. J Clin Oncol 1989;7:1310-1317.
5. Taal BG, ten Bokkel Huinink WW, Franklin H, Rodenhuis S: EAP in advanced gastric cancer [letter]. J Clin Oncol 1990;8:939-940.
6. Clark JL, Küçük Ö, Neuberg DS, et al.: Phase II trial of etoposide, doxorubicin, and cisplatin combination in advanced measurable gastric cancer: An Eastern Cooperative Oncology Group study. Am J Clin Oncol (CCT) 1995;18:318-324.
7. Lerner A, Gonin R, Steele GD Jr, Mayer RJ: Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric adenocarcinoma: Results of a phase II trial. J Clin Oncol 1992;10:536-540.
8. Kelsen D, Atiq OT, Saltz L, et al.: FAMTX versus etoposide, doxorubicin, and cisplatin: A random assignment trial in gastric cancer. J Clin Oncol 1992;10:541-548.
9. Beahrs OH, Henson DE, Hutter RVP, et al. (eds): "American Joint Committee on Cancer Manual for Staging of Cancer." 4th Ed. Philadelphia: JB Lippincott, 1992.
10. Oken MM, Creech LH, Tormey DC, et al.: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-655.
11. World Health Organization: "WHO Handbook for Reporting Results of Cancer Treatment." WHO Offset Publication NO. 48. Geneva: WHO, 1979.
12. Cox DR: "Analysis of Binary Data." London: Chapman & Hall, 1970.
13. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
14. Cox DR: Regression models and life tables. J R Stat Soc B 1972;34:187-220.
15. Wilke H, Preusser P, Fink U, et al.: New developments in treatment of gastric carcinoma. Semin Oncol 1990;17(suppl 2):61-70.
16. Wilke H, Preusser P, Fink U, et al.: Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: A phase II study with etoposide, doxorubicin, and cisplatin. J Clin Oncol 1989;7:1318-1326.
17. Katz A, Gansl RC, Simon SD, et al.: Phase II trial of etoposide (V), doxorubicin (A), and cisplatinum (P) in patients with metastatic gastric cancer. Am J Clin Oncol 1991;14:357-358.
18. Rath U, Flechtner H, Selbach J, et al.: Etoposide, adriamycin, and cisplatinum (EAP) combination chemotherapy for advanced gastric cancer. A phase II trial by the "Chemotherapiegruppe Gastrointestinaler Tumoren (CGT)." Onkologie 1990;13:194-197.
19. Ajani JA, Mayer RJ, Ota DM, et al.: Preoperative and postoperative combination chemotherapy for potentially resectable gastric-carcinoma. J Natl Cancer Inst 1993;85:1839-1844.
20. Haim N, Tsalik M, Robinson E: Treatment of gastric adenocarcinoma with the combination of etoposide, doxorubicin and cisplatin (EAP): Comparison between two schedules. Oncology 1994;51:102-107.
21. Bajetta E, Di Bartolomeo M, de Braud F, et al.: Etoposide, doxorubicin and cisplatin (EAP) treatment in advanced gastric carcinoma: A multicentre study of the Italian Trials in Medical Oncology (I.T.M.O.) Group. Eur J Cancer 1994;30A:596-600.
22. O'Connell MJ: Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric cancer: An old lesson revisited [editorial]. J Clin Oncol 1992;10:515-516.